InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2022-10-04 00:00:00 ET · period of report 2021-11-17 · accession 0000899243-22-032861 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-10-04 2022-10-03 DNA Kelly Jason R See remarks, Dir S - Sale+OE $3.12 -343.1K 26.21M -1% -$1.07M
DM 2022-10-04 2022-09-30+ DNA Kelly Jason R See remarks, Dir M - OptEx — +26.56M 26.56M New —
D 2022-10-04 2021-11-17 DNA Kelly Jason R See remarks, Dir A - Grant — +25.78M 25.78M New —
DM 2022-10-04 2022-09-30+ DNA Kelly Jason R See remarks, Dir M - OptEx — -26.56M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-10-03 S D 343,082 $3.12 26,212,725 D — —
2 Common Class A Common Stock 2022-09-30 M A 773,453 — 773,453 D — — (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
3 Common Class A Common Stock 2022-10-01 M A 25,782,354 — 26,555,807 D — — (F3) Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.
4 Derivative Restricted Stock Units 2021-11-17 A A 25,782,354 — 25,782,354 D — · — to — — Class A Common Stock (F3) Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.
5 Derivative Class B Common Stock 2022-09-30 M D 773,453 — 69,929,596 D — · — to — — Class A Common Stock (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. (F5) Includes shares of Class B Common Stock that are subject to vesting conditions.
6 Derivative Restricted Stock Units 2022-10-01 M D 25,782,354 — 0 D — · — to — — Class A Common Stock (F3) Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.